Apr 28, 2020
Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs
Nov 04, 2019
Pulmatrix appoints Life Sciences Executive Rick Batycky to the Board of Directors
Jul 24, 2019
Parkinson's Disease Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Jun 25, 2019
New National Event Series "Parkinson's IQ + You" Launches to Educate and Empower Parkinson's Disease Patients and Care Partners
Jun 04, 2019
Theravance Biopharma Appoints Andrew Hindman as Senior Vice President and Chief Financial Officer
Mar 26, 2019
Rigel Welcomes Jane Wasman to Board of Directors
Dec 26, 2018
Early Investment from Michael J. Fox Foundation Pushes New Parkinson's Treatment to Market
Nov 14, 2018
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
Nov 05, 2018
Grünenthal Acquires Global Rights for Qutenza®
Aug 01, 2018
Parkinson's Disease Market 2018 by Phase of Development, Type of Treatment, Type of Molecule, Mechanism of Action, Route of Administration, and Leading Players
Jul 19, 2018
Free Technical Briefing on Biotech Stocks -- ARCA biopharma, Achieve Life Sciences, Acorda Therapeutics, and Adaptimmune Therapeutics
Apr 23, 2018
Parkinson's Disease Therapeutics Market to Exceed the US$ 5.24 Bn by 2025, Says TMR
Apr 09, 2018
Technical Perspectives on Biotech Stocks -- ACADIA Pharma, Achaogen, Achillion Pharma, and Acorda Therapeutics
Feb 05, 2018
Technical Perspectives on Biotech Stocks -- ACADIA Pharma, Achaogen, Achillion Pharma, and Acorda Therapeutics
Feb 01, 2018
Orphan Drugs Market Report 2018-2028
Jan 24, 2018
Global Parkinson's Disease Drug Market Forecast 2018-2028
Jan 04, 2018
Quotidian Technical Highlights on Selected Biotech Stocks -- Juno Therapeutics, Acorda Therapeutics, Lexicon Pharma, and FibroGen
Dec 01, 2017
Amarantus Provides Comprehensive Corporate Update
Nov 28, 2017
Stock Review for Biotech's Investors -- Spark Therapeutics, Agenus, Coherus Biosciences, and Acorda Therapeutics
Nov 15, 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR